202 related articles for article (PubMed ID: 31042586)
21. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
Ishii Y; Waxman S; Germain D
Cancer Res; 2008 Feb; 68(3):852-60. PubMed ID: 18245487
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of TMEM16A Ca
Zhang X; Zhang G; Zhai W; Zhao Z; Wang S; Yi J
Pharmacol Res; 2020 Jun; 156():104763. PubMed ID: 32201246
[TBL] [Abstract][Full Text] [Related]
23. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer.
Berclaz G; Altermatt HJ; Rohrbach V; Siragusa A; Dreher E; Smith PD
Int J Oncol; 2001 Dec; 19(6):1155-60. PubMed ID: 11713584
[TBL] [Abstract][Full Text] [Related]
24. PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.
Selitrennik M; Lev S
Oncotarget; 2015 Sep; 6(26):22214-26. PubMed ID: 26084289
[TBL] [Abstract][Full Text] [Related]
25. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
26. Regulation of TMEM16A/ANO1 and TMEM16F/ANO6 ion currents and phospholipid scrambling by Ca
Schreiber R; Ousingsawat J; Wanitchakool P; Sirianant L; Benedetto R; Reiss K; Kunzelmann K
J Physiol; 2018 Jan; 596(2):217-229. PubMed ID: 29134661
[TBL] [Abstract][Full Text] [Related]
27. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop.
Liu X; Wang J; Wang H; Yin G; Liu Y; Lei X; Xiang M
Cancer Lett; 2015 Jun; 362(1):45-60. PubMed ID: 25779676
[TBL] [Abstract][Full Text] [Related]
28. Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
Choi HJ; Joo HS; Won HY; Min KW; Kim HY; Son T; Oh YH; Lee JY; Kong G
J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028222
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
30. Compartmentalized crosstalk of CFTR and TMEM16A (ANO1) through EPAC1 and ADCY1.
Lérias J; Pinto M; Benedetto R; Schreiber R; Amaral M; Aureli M; Kunzelmann K
Cell Signal; 2018 Apr; 44():10-19. PubMed ID: 29331508
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
32. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression.
Duvvuri U; Shiwarski DJ; Xiao D; Bertrand C; Huang X; Edinger RS; Rock JR; Harfe BD; Henson BJ; Kunzelmann K; Schreiber R; Seethala RS; Egloff AM; Chen X; Lui VW; Grandis JR; Gollin SM
Cancer Res; 2012 Jul; 72(13):3270-81. PubMed ID: 22564524
[TBL] [Abstract][Full Text] [Related]
33. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
[TBL] [Abstract][Full Text] [Related]
34. Effect of bisphenol A on the EGFR-STAT3 pathway in MCF-7 breast cancer cells.
Zhang W; Fang Y; Shi X; Zhang M; Wang X; Tan Y
Mol Med Rep; 2012 Jan; 5(1):41-7. PubMed ID: 21909620
[TBL] [Abstract][Full Text] [Related]
35. Epithelial Chloride Transport by CFTR Requires TMEM16A.
Benedetto R; Ousingsawat J; Wanitchakool P; Zhang Y; Holtzman MJ; Amaral M; Rock JR; Schreiber R; Kunzelmann K
Sci Rep; 2017 Sep; 7(1):12397. PubMed ID: 28963502
[TBL] [Abstract][Full Text] [Related]
36. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of Ca2+-activated Cl- channel TMEM16A by the inhibition of histone deacetylase in TMEM16A-expressing cancer cells.
Matsuba S; Niwa S; Muraki K; Kanatsuka S; Nakazono Y; Hatano N; Fujii M; Zhan P; Suzuki T; Ohya S
J Pharmacol Exp Ther; 2014 Dec; 351(3):510-8. PubMed ID: 25232193
[TBL] [Abstract][Full Text] [Related]
38. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
39. Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer.
Bui QT; Im JH; Jeong SB; Kim YM; Lim SC; Kim B; Kang KW
Cancer Lett; 2017 Apr; 390():115-125. PubMed ID: 28108315
[TBL] [Abstract][Full Text] [Related]
40. [Involvement of epidermal growth factor receptor signaling pathway in tamoxifen resistance of MCF-7 cells].
Zhen LL; Zhu X; Zheng W; Wang XY; Wu ZY
Ai Zheng; 2006 Jul; 25(7):839-43. PubMed ID: 16831274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
